Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-003495
Filing Date
2023-04-07
Accepted
2023-04-07 11:30:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27647
2 filename2.txt TEXT-EXTRACT 1487
  Complete submission text file 0000000000-23-003495.txt   40265
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filed for) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)